Literature DB >> 23880807

Ambulatory blood pressure monitoring for children with β-thalassemia major: a preliminary report.

Morteza Tabatabaie1, Nakysa Hooman, Khadijeh Arjmandi-Rafsanjani, Roya Isa-Tafreshi.   

Abstract

INTRODUCTION: Heart disease is one of the most common reasons of death in beta-thalassemia major. A few studies have been done in children about blood pressure changes. The aim of this study was to assess hemodynamic changes by ambulatory blood pressure monitoring (ABPM).
MATERIALS AND METHODS: In this cross-sectional study, 30 patients with beta-thalassemia major aged 5 to 18 years old were evaluated with 24-hour ABPM. The exclusion criteria were an ejection Fraction less than 50% and a glomerular filtration rate less than 90 mL/min/1.73 m2. Hypertension was defined as a mean blood pressure index of 1 and greater with or without load blood pressure greater than 25%. Dipper status was defined as a 10% decrease in nighttime versus daytime mean arterial blood pressure.
RESULTS: High blood pressure was detected in 16.7% of the patients. The whole-day ABPM showed hypertension in 6.7% of the children. During daytime measurements, systolic hypertension was seen in 3.3% (load 3.7%) and diastolic in 6.7% (load 3.3%). These figures for nighttime evaluation were 6.7% (load 3.3%) and 10.3% (load 6.9%), respectively. Nondipper status was detected in 56.7% of the children. There was no significant correlation between abnormal blood pressure and age, sex, body mass index, hemoglobin, number or rates of blood transfusion, or serum ferritin level.
CONCLUSIONS: The ABPM may be a useful instrument for early detection of hemodynamic changes in children with beta-thalassemia major.

Entities:  

Mesh:

Year:  2013        PMID: 23880807

Source DB:  PubMed          Journal:  Iran J Kidney Dis        ISSN: 1735-8582            Impact factor:   0.892


  2 in total

1.  Clinical Usefulness of Furosemide to Prevent Volume Overload Among Children and Young Adults with Transfusion-Dependent Thalassemia: A Randomized, Open-Label, Crossover Study.

Authors:  Apichat Photia; Chanchai Traivaree; Chalinee Monsereenusorn; Piyarat Simthamnimit; Piya Rujkijyanont
Journal:  J Blood Med       Date:  2020-12-29

2.  Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats.

Authors:  Suwakon Wongjaikam; Sirinart Kumfu; Juthamas Khamseekaew; Jirapas Sripetchwandee; Somdet Srichairatanakool; Suthat Fucharoen; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.